Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve audited financial results ....
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech has informed the BSE that its Board of Directors will meet on Wednesday, May 28, 2025. On the agenda: (1) approval of audited standalone and consolidated financial results for Q4 and full financial year ended March 31, 2025; (2) consideration and recommendation of a final equity dividend for FY2024-25, if any; and (3) adoption of a new Employee Stock Option Scheme called 'ESOP 2025', to be implemented through an ESOP Trust, subject to shareholder approval. The company also noted that the trading window for its securities is already closed and will remain closed until 48 hours after the audited results are declared.
Investors should watch for the audited FY25 results, any dividend declaration, and the proposed ESOP 2025 scheme on May 28 — these could influence short-term stock movement and shareholder returns. The new ESOP, if approved, may lead to equity dilution over time.